Siegel , Daniel, Christopher Murphy, Kent Wangsness, Allyson Perry, and Ian Smith. 2022. “Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma”. SKIN The Journal of Cutaneous Medicine 6 (2):109-21. https://doi.org/10.25251/skin.6.2.4.